Denali Advisors’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-34,616
| Closed | -$650K | – | 306 |
|
2024
Q3 | $650K | Sell |
34,616
-146,051
| -81% | -$2.74M | 0.07% | 219 |
|
2024
Q2 | $3.41M | Sell |
180,667
-52,229
| -22% | -$987K | 0.93% | 44 |
|
2024
Q1 | $3.78M | Buy |
232,896
+114,515
| +97% | +$1.86M | 1.11% | 33 |
|
2023
Q4 | $1.5M | Buy |
118,381
+91,348
| +338% | +$1.16M | 0.46% | 64 |
|
2023
Q3 | $368K | Sell |
27,033
-61,261
| -69% | -$834K | 0.13% | 170 |
|
2023
Q2 | $1.52M | Sell |
88,294
-70,899
| -45% | -$1.22M | 0.53% | 57 |
|
2023
Q1 | $2.22M | Sell |
159,193
-48,698
| -23% | -$678K | 0.92% | 41 |
|
2022
Q4 | $2.78M | Sell |
207,891
-4,064
| -2% | -$54.4K | 1.17% | 38 |
|
2022
Q3 | $2.52M | Sell |
211,955
-111,546
| -34% | -$1.33M | 1.19% | 37 |
|
2022
Q2 | $4.12M | Buy |
323,501
+52,339
| +19% | +$666K | 1.79% | 4 |
|
2022
Q1 | $3.51M | Buy |
271,162
+51,783
| +24% | +$669K | 1.35% | 32 |
|
2021
Q4 | $3.48M | Buy |
219,379
+79,548
| +57% | +$1.26M | 1.3% | 27 |
|
2021
Q3 | $2.73M | Buy |
139,831
+139,757
| +188,861% | +$2.72M | 1.14% | 35 |
|
2021
Q2 | $2K | Hold |
74
| – | – | ﹤0.01% | 258 |
|
2021
Q1 | $1K | Buy |
+74
| New | +$1K | ﹤0.01% | 362 |
|
2016
Q2 | – | Sell |
-384
| Closed | -$2K | – | 314 |
|
2016
Q1 | $2K | Hold |
384
| – | – | ﹤0.01% | 216 |
|
2015
Q4 | $2K | Hold |
384
| – | – | ﹤0.01% | 217 |
|
2015
Q3 | $2K | Hold |
384
| – | – | ﹤0.01% | 225 |
|
2015
Q2 | $3K | Hold |
384
| – | – | ﹤0.01% | 192 |
|
2015
Q1 | $3K | Hold |
384
| – | – | ﹤0.01% | 185 |
|
2014
Q4 | $3K | Hold |
384
| – | – | ﹤0.01% | 166 |
|
2014
Q3 | $2K | Hold |
384
| – | – | ﹤0.01% | 188 |
|
2014
Q2 | $3K | Sell |
384
-126
| -25% | -$984 | ﹤0.01% | 175 |
|
2014
Q1 | $3K | Hold |
510
| – | – | ﹤0.01% | 186 |
|
2013
Q4 | $3K | Hold |
510
| – | – | ﹤0.01% | 183 |
|
2013
Q3 | $2K | Hold |
510
| – | – | ﹤0.01% | 157 |
|
2013
Q2 | $2K | Buy |
+510
| New | +$2K | ﹤0.01% | 152 |
|